| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT06908226 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… |
Trial sites expanded: 68 -> 81 locations |
| 2026-08-13 | NCT06719141 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… |
Enrollment increased: 292 -> 367 participants |
| 2026-08-11 | NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With… |
Enrollment reduced: 160 -> 104 participants |
| 2026-07-19 | NCT06908226 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… |
Trial sites expanded: 16 -> 68 locations |
| 2026-07-19 | NCT06719141 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… |
overall status: Recruiting → Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06660394 | A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With… | Dravet Syndrome | Recruiting |
| NCT06719141 | A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… | Developmental and Epileptic Encephalopathy | Active, Not Recruiting |
| NCT06908226 | A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic… | Developmental and Epileptic Encephalopathy | Enrolling by Invitation |